tiprankstipranks
Trending News
More News >
Arcellx Inc (ACLX)
NASDAQ:ACLX
US Market

Arcellx Inc (ACLX) Stock Forecast & Price Target

Compare
317 Followers
See the Price Targets and Ratings of:

ACLX Analyst Ratings

Hold
15Ratings
Hold
0 Buy
15 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Arcellx
Inc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ACLX Stock 12 Month Forecast

Average Price Target

$112.67
▼(-1.50% Downside)
Based on 15 Wall Street analysts offering 12 month price targets for Arcellx Inc in the last 3 months. The average price target is $112.67 with a high forecast of $120.00 and a low forecast of $82.00. The average price target represents a -1.50% change from the last price of $114.39.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"59":"$59","90":"$90","121":"$121","74.5":"$74.5","105.5":"$105.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":120,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$120.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":112.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$112.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":82,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$82.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[59,74.5,90,105.5,121],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,114.05,114.50769230769231,114.96538461538461,115.42307692307692,115.88076923076923,116.33846153846153,116.79615384615384,117.25384615384615,117.71153846153847,118.16923076923077,118.62692307692308,119.08461538461539,119.54230769230769,{"y":120,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,114.05,113.94384615384615,113.83769230769231,113.73153846153846,113.62538461538462,113.51923076923077,113.41307692307693,113.30692307692307,113.20076923076923,113.09461538461538,112.98846153846154,112.88230769230769,112.77615384615385,{"y":112.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,114.05,111.58461538461538,109.11923076923077,106.65384615384615,104.18846153846154,101.72307692307692,99.25769230769231,96.79230769230769,94.32692307692308,91.86153846153846,89.39615384615385,86.93076923076923,84.46538461538461,{"y":82,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":64.82,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.7,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.53,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.93,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.69,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.14,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.75,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.03,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.25,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.28,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.2,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.47,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":114.05,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$120.00Average Price Target$112.67Lowest Price Target$82.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on ACLX
Truist Financial
Truist Financial
$120
Hold
4.90%
Upside
Reiterated
03/02/26
Truist Financial Keeps Their Hold Rating on Arcellx Inc (ACLX)
William Blair Analyst forecast on ACLX
William Blair
William Blair
Hold
Reiterated
02/28/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (NASDAQ: ACLX), Alkermes (NASDAQ: ALKS) and Progyny (NASDAQ: PGNY)
TD Cowen
Hold
Downgraded
02/27/26
Analysts Offer Insights on Healthcare Companies: Arcellx Inc (NASDAQ: ACLX) and Apellis Pharmaceuticals (NASDAQ: APLS)
Needham Analyst forecast on ACLX
Needham
Needham
Hold
Reiterated
02/27/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Arcellx Inc (NASDAQ: ACLX) and Pacira Pharmaceuticals (NASDAQ: PCRX)
Guggenheim Analyst forecast on ACLX
Guggenheim
Guggenheim
$120$115
Hold
0.53%
Upside
Downgraded
02/25/26
Arcellx downgraded to Neutral from Buy at GuggenheimArcellx downgraded to Neutral from Buy at Guggenheim
UBS
$100$115
Hold
0.53%
Upside
Downgraded
02/25/26
Arcellx downgraded to Neutral from Buy at UBSArcellx downgraded to Neutral from Buy at UBS
Wells Fargo Analyst forecast on ACLX
Wells Fargo
Wells Fargo
$100$115
Hold
0.53%
Upside
Downgraded
02/24/26
Arcellx downgraded to Equal Weight from Overweight at Wells FargoArcellx downgraded to Equal Weight from Overweight at Wells Fargo
Stifel Nicolaus Analyst forecast on ACLX
Stifel Nicolaus
Stifel Nicolaus
$127$115
Hold
0.53%
Upside
Downgraded
02/24/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcellx Inc (NASDAQ: ACLX) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)
Robert W. Baird Analyst forecast on ACLX
Robert W. Baird
Robert W. Baird
$106$115
Hold
0.53%
Upside
Downgraded
02/24/26
Arcellx downgraded to Neutral from Outperform at BairdArcellx downgraded to Neutral from Outperform at Baird
Evercore ISI Analyst forecast on ACLX
Evercore ISI
Evercore ISI
$115
Hold
0.53%
Upside
Downgraded
02/23/26
Arcellx downgraded to In Line from Outperform at Evercore ISIArcellx downgraded to In Line from Outperform at Evercore ISI
Citi
$110$115
Hold
0.53%
Upside
Downgraded
02/23/26
Arcellx downgraded to Neutral from Buy at CitiArcellx downgraded to Neutral from Buy at Citi
H.C. Wainwright Analyst forecast on ACLX
H.C. Wainwright
H.C. Wainwright
$115
Hold
0.53%
Upside
Downgraded
02/23/26
Arcellx downgraded to Neutral from Buy at H.C. WainwrightArcellx downgraded to Neutral from Buy at H.C. Wainwright
Canaccord Genuity Analyst forecast on ACLX
Canaccord Genuity
Canaccord Genuity
$130$115
Hold
0.53%
Upside
Downgraded
02/23/26
Arcellx downgraded to Hold from Buy at CanaccordArcellx downgraded to Hold from Buy at Canaccord
Leerink Partners Analyst forecast on ACLX
Leerink Partners
Leerink Partners
$115
Hold
0.53%
Upside
Downgraded
02/23/26
Arcellx downgraded to Market Perform from Outperform at LeerinkArcellx downgraded to Market Perform from Outperform at Leerink
Rothschild & Co Redburn Analyst forecast on ACLX
Rothschild & Co Redburn
Rothschild & Co Redburn
$113$82
Hold
-28.32%
Downside
Downgraded
02/12/26
Arcellx downgraded to Neutral from Buy at Rothschild & Co RedburnArcellx downgraded to Neutral from Buy at Rothschild & Co Redburn
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on ACLX
Truist Financial
Truist Financial
$120
Hold
4.90%
Upside
Reiterated
03/02/26
Truist Financial Keeps Their Hold Rating on Arcellx Inc (ACLX)
William Blair Analyst forecast on ACLX
William Blair
William Blair
Hold
Reiterated
02/28/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (NASDAQ: ACLX), Alkermes (NASDAQ: ALKS) and Progyny (NASDAQ: PGNY)
TD Cowen
Hold
Downgraded
02/27/26
Analysts Offer Insights on Healthcare Companies: Arcellx Inc (NASDAQ: ACLX) and Apellis Pharmaceuticals (NASDAQ: APLS)
Needham Analyst forecast on ACLX
Needham
Needham
Hold
Reiterated
02/27/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Arcellx Inc (NASDAQ: ACLX) and Pacira Pharmaceuticals (NASDAQ: PCRX)
Guggenheim Analyst forecast on ACLX
Guggenheim
Guggenheim
$120$115
Hold
0.53%
Upside
Downgraded
02/25/26
Arcellx downgraded to Neutral from Buy at GuggenheimArcellx downgraded to Neutral from Buy at Guggenheim
UBS
$100$115
Hold
0.53%
Upside
Downgraded
02/25/26
Arcellx downgraded to Neutral from Buy at UBSArcellx downgraded to Neutral from Buy at UBS
Wells Fargo Analyst forecast on ACLX
Wells Fargo
Wells Fargo
$100$115
Hold
0.53%
Upside
Downgraded
02/24/26
Arcellx downgraded to Equal Weight from Overweight at Wells FargoArcellx downgraded to Equal Weight from Overweight at Wells Fargo
Stifel Nicolaus Analyst forecast on ACLX
Stifel Nicolaus
Stifel Nicolaus
$127$115
Hold
0.53%
Upside
Downgraded
02/24/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcellx Inc (NASDAQ: ACLX) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)
Robert W. Baird Analyst forecast on ACLX
Robert W. Baird
Robert W. Baird
$106$115
Hold
0.53%
Upside
Downgraded
02/24/26
Arcellx downgraded to Neutral from Outperform at BairdArcellx downgraded to Neutral from Outperform at Baird
Evercore ISI Analyst forecast on ACLX
Evercore ISI
Evercore ISI
$115
Hold
0.53%
Upside
Downgraded
02/23/26
Arcellx downgraded to In Line from Outperform at Evercore ISIArcellx downgraded to In Line from Outperform at Evercore ISI
Citi
$110$115
Hold
0.53%
Upside
Downgraded
02/23/26
Arcellx downgraded to Neutral from Buy at CitiArcellx downgraded to Neutral from Buy at Citi
H.C. Wainwright Analyst forecast on ACLX
H.C. Wainwright
H.C. Wainwright
$115
Hold
0.53%
Upside
Downgraded
02/23/26
Arcellx downgraded to Neutral from Buy at H.C. WainwrightArcellx downgraded to Neutral from Buy at H.C. Wainwright
Canaccord Genuity Analyst forecast on ACLX
Canaccord Genuity
Canaccord Genuity
$130$115
Hold
0.53%
Upside
Downgraded
02/23/26
Arcellx downgraded to Hold from Buy at CanaccordArcellx downgraded to Hold from Buy at Canaccord
Leerink Partners Analyst forecast on ACLX
Leerink Partners
Leerink Partners
$115
Hold
0.53%
Upside
Downgraded
02/23/26
Arcellx downgraded to Market Perform from Outperform at LeerinkArcellx downgraded to Market Perform from Outperform at Leerink
Rothschild & Co Redburn Analyst forecast on ACLX
Rothschild & Co Redburn
Rothschild & Co Redburn
$113$82
Hold
-28.32%
Downside
Downgraded
02/12/26
Arcellx downgraded to Neutral from Buy at Rothschild & Co RedburnArcellx downgraded to Neutral from Buy at Rothschild & Co Redburn
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Arcellx Inc

3 Months
xxx
Success Rate
8/11 ratings generated profit
73%
Average Return
+24.38%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +24.38% per trade.
1 Year
Jason GerberryBank of America Securities
Success Rate
20/22 ratings generated profit
91%
Average Return
+53.00%
reiterated a buy rating 3 months ago
Copying Jason Gerberry's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +53.00% per trade.
2 Years
xxx
Success Rate
11/11 ratings generated profit
100%
Average Return
+94.80%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +94.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ACLX Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
8
18
27
25
14
Buy
21
24
15
5
2
Hold
19
23
17
25
22
Sell
1
2
2
1
0
Strong Sell
0
0
0
0
0
total
49
67
61
56
38
In the current month, ACLX has received 16 Buy Ratings, 22 Hold Ratings, and 0 Sell Ratings. ACLX average Analyst price target in the past 3 months is 112.67.
Each month's total comprises the sum of three months' worth of ratings.

ACLX Financial Forecast

ACLX Earnings Forecast

The previous quarter’s earnings for ACLX were -$1.00.
The previous quarter’s earnings for ACLX were -$1.00.

ACLX Sales Forecast

The previous quarter’s earnings for ACLX were $1.65M.
The previous quarter’s earnings for ACLX were $1.65M.

ACLX Stock Forecast FAQ

What is ACLX’s average 12-month price target, according to analysts?
Based on analyst ratings, Arcellx Inc’s 12-month average price target is 112.67.
    What is ACLX’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for ACLX, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is ACLX a Buy, Sell or Hold?
        Arcellx Inc has a consensus rating of Hold which is based on 0 buy ratings, 15 hold ratings and 0 sell ratings.
          What is Arcellx Inc’s price target?
          The average price target for Arcellx Inc is 112.67. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $120.00 ,the lowest forecast is $82.00. The average price target represents -1.50% Decrease from the current price of $114.39.
            What do analysts say about Arcellx Inc?
            Arcellx Inc’s analyst rating consensus is a Hold. This is based on the ratings of 15 Wall Streets Analysts.
              How can I buy shares of ACLX?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.